OpenAI on Thursday announced the acquisition of Astral, the developer of open source Python tools that include uv, Ruff and ty. It says that it plans to integrate them with Codex, its AI coding agent ...

Seriously? Astral's tools aren't even AI-focused, and now they're tied to a company that's losing money hand over fist? Click to expand... I'm guessing that a fair amount of stuff around AI (be it ...

OpenAI said on Thursday it will acquire Astral, as the ChatGPT maker doubles down on artificial intelligence-powered coding tools to compete more aggressively with rivals such as Anthropic. The ...

Scientists Were Studying Snake Blood For Other Reasons. What They Found Could Change Obesity Treatment. In A Nutshell Scientists discovered a molecule called pTOS in python blood that surges after ...

OpenAI acquires Astral, the Python toolmaker, to enhance Codex AI coding assistant as it competes with Anthropic's Claude Code and Cursor.

OpenAI's most significant competitors in the AI coding space include Cursor and Anthropic ( ANTHRO ). Cursor is in talks with investors for a funding round that would value the startup at about $50B.

People lament the state of our tech sector, but several booming companies bring Monty Python to mind: We’re not dead yet.

This investigation was supported by the Pulitzer Center’s Artificial Intelligence Accountability Network  Investigative ...

You can now run LLMs for software development on consumer-grade PCs. But we’re still a ways off from having Claude at home.

Apple cut App Store fees in mainland China to 25%, with some reduced-rate commissions falling to 12% after talks with regulators.

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Push-ups work your chest, arms, core, and legs all at ...

This is a complete blueprint for implementing a production-grade, multi-layer memory system for OpenClaw that provides persistent, searchable, cross-session context — just like Jarvis from Iron Man.